Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurofibromatosis type 1 as a model system to study molecular mechanisms of autism spectrum disorder symptoms
Andrei I. Molosh, Anantha Shekhar
Progress in brain research (2018), pp. 37-62
Closed Access | Times Cited: 18

Showing 18 citing articles:

RAS and beyond: the many faces of the neurofibromatosis type 1 protein
Corina Anastasaki, Paola Orozco, David H. Gutmann
Disease Models & Mechanisms (2022) Vol. 15, Iss. 2
Open Access | Times Cited: 42
Delineating the autistic phenotype in children with neurofibromatosis type 1
Anita K. Chisholm, Kristina M. Haebich, Natalie A. Pride, et al.
Molecular Autism (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 19
Social skills and autism spectrum disorder symptoms in children with neurofibromatosis type 1: evidence for clinical trial outcomes
Jonathan M. Payne, Karin S. Walsh, Natalie A. Pride, et al.
Developmental Medicine & Child Neurology (2020) Vol. 62, Iss. 7, pp. 813-819
Open Access | Times Cited: 23
16p11.2 deletion mice exhibit compromised fronto-temporal connectivity, GABAergic dysfunction, and enhanced attentional ability
Rebecca L. Openshaw, David M. Thomson, Greg C. Bristow, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 6
A Targeted, Low-Throughput Compound Screen in aDrosophilaModel of Neurofibromatosis Type 1 Identifies Simvastatin and BMS-204352 as Potential Therapies for Autism Spectrum Disorder (ASD)
Alex Dyson, Megan Ryan, Shruti Garg, et al.
eNeuro (2023) Vol. 10, Iss. 5, pp. ENEURO.0461-22.2023
Open Access | Times Cited: 5
Exploring the Molecular Landscape of Myelofibrosis, with a Focus on Ras and Mitogen-Activated Protein (MAP) Kinase Signaling
Samuel B Reynolds, Kristen Pettit, Malathi Kandarpa, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4654-4654
Open Access | Times Cited: 4
Guanfacine treatment improves ADHD phenotypes of impulsivity and hyperactivity in a neurofibromatosis type 1 mouse model
Jodi L. Lukkes, H. P. Drozd, Stephanie D. Fitz, et al.
Journal of Neurodevelopmental Disorders (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Social behaviors and contextual memory of Vcp mutant mice are sensitive to nutrition and can be ameliorated by amino acid supplementation
Tzyy‐Nan Huang, Yu‐Tzu Shih, Si-Cih Lin, et al.
iScience (2020) Vol. 24, Iss. 1, pp. 101949-101949
Open Access | Times Cited: 6
The Self-Concept, Family Functioning, Psychological and Emotional Symptoms, in Children and Adolescents with Neurofibromatosis Type 1
Gülen Güler, Özlem Tezol, Meryem Özlem Kütük, et al.
Düzce Tıp Fakültesi Dergisi (2024)
Open Access
Mitochondrial Dysfunction and mTOR in Autism Spectrum Disorders
Ezgi SELAMET, Miraç Barış Usta
Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry (2023) Vol. 15, Iss. 4, pp. 697-704
Open Access | Times Cited: 1
Psychiatric disorders in patients with neurofibromatosis
Marija Bogadi, Snježana Kaštelan, Ivana Bakija, et al.
Libri Oncologici Croatian Journal of Oncology (2019) Vol. 46, Iss. 2-3, pp. 106-112
Open Access | Times Cited: 2
A targeted, low-throughput compound screen in aDrosophilamodel of neurofibromatosis type 1 identifies simvastatin and BMS-204352 as potential therapies for autism spectrum disorder (ASD)
Alex Dyson, Megan Ryan, Shruti Garg, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Targeted Sequencing Detects Variants That May Contribute to the Risk of Neuropsychiatric Disorders
Jayant Mahadevan, Reeteka Sud, Ravi Kumar Nadella, et al.
Indian Journal of Psychological Medicine (2021) Vol. 44, Iss. 5, pp. 516-522
Open Access | Times Cited: 1
Neurofibromatosis Type I and autism spectrum disorder caused by deletion of the NF1 gene: A case report
Luyang Guan, Jinhui Li, Ziyi Zhang, et al.
Asian Journal of Psychiatry (2023) Vol. 84, pp. 103544-103544
Closed Access
An audit and insights from clinical exome sequencing in psychiatry: genotype-phenotype correlation
Jayant Mahadevan, Reeteka Sud, Ravi Kumar Nadella, et al.
(2020)
Open Access
Neurofibromatosis type 1
Inês Bernardino, Joana Gonçalves, Miguel Castelo‐Branco
Elsevier eBooks (2021), pp. 115-126
Closed Access
Social cognition in autism spectrum disorder and neurogenetic syndromes
Alice Maier, Nicholas P. Ryan, Anita K. Chisholm, et al.
Routledge eBooks (2021), pp. 108-144
Closed Access
Prospects for Targeted Kinase Inhibition in Cancer: Neurofibromatosis Type 1-Related Neoplasia
Steven D. Rhodes, Steven P. Angus
Elsevier eBooks (2021), pp. 262-276
Closed Access
Page 1

Scroll to top